AAPL344.17-5.34 (-1.53%) ▼|ABBV288.24-6.59 (-2.24%) ▼|ABT113.60-1.91 (-1.65%) ▼|ACN265.16+0.89 (+0.34%) ▲|ADBE246.44-2.04 (-0.82%) ▼|AMAT319.25-50.15 (-13.58%) ▼|AMD404.40-84.38 (-17.26%) ▼|AMGN460.28-18.20 (-3.80%) ▼|AMT193.99-0.87 (-0.45%) ▼|AMZN260.21-5.82 (-2.19%) ▼|AVGO291.53-33.95 (-10.43%) ▼|AXP324.97-7.62 (-2.29%) ▼|BA172.50-4.50 (-2.54%) ▼|BAC49.76-1.87 (-3.62%) ▼|BKNG168.72-2.25 (-1.32%) ▼|BLK1,170.67-53.70 (-4.39%) ▼|BMY63.13-1.06 (-1.65%) ▼|BNY147.85-4.87 (-3.19%) ▼|BRK-B573.80-5.29 (-0.91%) ▼|C118.76-5.98 (-4.79%) ▼|CAT558.42-32.88 (-5.56%) ▼|CL98.81+0.05 (+0.05%) ▲|CMCSA24.81-0.05 (-0.18%) ▼|COF203.62-2.69 (-1.30%) ▼|COP137.51+0.57 (+0.42%) ▲|COST1,064.37+17.90 (+1.71%) ▲|CRM220.88-6.23 (-2.74%) ▼|CSCO96.04-7.57 (-7.31%) ▼|CVS80.35+0.39 (+0.48%) ▲|CVX215.74-1.22 (-0.56%) ▼|DE663.35-13.15 (-1.94%) ▼|DHR227.58-7.35 (-3.13%) ▼|DIS117.48-1.47 (-1.24%) ▼|DUK130.13+0.54 (+0.42%) ▲|EMR163.56-6.89 (-4.04%) ▼|FDX318.11-11.29 (-3.43%) ▼|GD358.91-5.96 (-1.63%) ▼|GE315.90-13.56 (-4.11%) ▼|GEV777.05-55.79 (-6.70%) ▼|GILD168.00-6.48 (-3.71%) ▼|GM89.14-3.29 (-3.56%) ▼|GOOG283.61-3.70 (-1.29%) ▼|GOOGL284.49-4.45 (-1.54%) ▼|GS871.57-56.43 (-6.08%) ▼|HD350.85-4.59 (-1.29%) ▼|HON216.94-11.53 (-5.05%) ▼|IBM247.77-6.55 (-2.58%) ▼|INTC53.58-4.69 (-8.05%) ▼|INTU351.82-4.82 (-1.35%) ▼|ISRG464.30-17.80 (-3.69%) ▼|JNJ272.50-3.82 (-1.38%) ▼|JPM337.31-14.80 (-4.20%) ▼|KO95.68-0.12 (-0.13%) ▼|LIN518.86-5.88 (-1.12%) ▼|LLY1,375.38-42.62 (-3.01%) ▼|LMT578.77-16.27 (-2.73%) ▼|LOW228.41-0.97 (-0.42%) ▼|LRCX190.22-31.22 (-14.10%) ▼|MA656.44-16.24 (-2.41%) ▼|MCD277.35-2.88 (-1.03%) ▼|MDLZ66.91-0.47 (-0.70%) ▼|MDT104.03-0.93 (-0.89%) ▼|META606.01-23.99 (-3.81%) ▼|MMM188.78-5.18 (-2.67%) ▼|MO77.34-0.67 (-0.86%) ▼|MRK147.31-3.05 (-2.03%) ▼|MS183.25-10.73 (-5.53%) ▼|MSFT535.26-20.54 (-3.70%) ▼|MU676.64-118.59 (-14.91%) ▼|NEE88.08-0.37 (-0.42%) ▼|NFLX64.88-1.52 (-2.28%) ▼|NKE39.45-1.05 (-2.58%) ▼|NOW102.06-6.75 (-6.20%) ▼|NVDA182.90-17.23 (-8.61%) ▼|ORCL115.23-8.50 (-6.87%) ▼|PEP143.42+1.00 (+0.70%) ▲|PFE30.09-0.70 (-2.27%) ▼|PG166.58-0.74 (-0.44%) ▼|PLTR155.02-16.68 (-9.71%) ▼|PM202.55-8.73 (-4.13%) ▼|QCOM158.93-14.26 (-8.23%) ▼|RTX192.54-5.89 (-2.97%) ▼|SBUX106.99-2.71 (-2.47%) ▼|SCHW92.64-0.73 (-0.78%) ▼|SO92.64-0.49 (-0.52%) ▼|SPG226.35-2.15 (-0.94%) ▼|T21.69-0.15 (-0.66%) ▼|TMO681.30-24.87 (-3.52%) ▼|TMUS159.77+0.60 (+0.38%) ▲|TSLA342.63-42.56 (-11.05%) ▼|TXN285.01-26.49 (-8.50%) ▼|UBER68.37-1.50 (-2.15%) ▼|UNH396.74-12.64 (-3.09%) ▼|UNP296.03-12.50 (-4.05%) ▼|UPS110.69-3.62 (-3.17%) ▼|USB59.48-1.55 (-2.54%) ▼|V424.45-12.12 (-2.78%) ▼|VZ46.12-0.06 (-0.12%) ▼|WFC84.48-2.95 (-3.37%) ▼|WMT128.11-1.06 (-0.82%) ▼|XOM167.58-1.70 (-1.00%) ▼|AAPL344.17-5.34 (-1.53%) ▼|ABBV288.24-6.59 (-2.24%) ▼|ABT113.60-1.91 (-1.65%) ▼|ACN265.16+0.89 (+0.34%) ▲|ADBE246.44-2.04 (-0.82%) ▼|AMAT319.25-50.15 (-13.58%) ▼|AMD404.40-84.38 (-17.26%) ▼|AMGN460.28-18.20 (-3.80%) ▼|AMT193.99-0.87 (-0.45%) ▼|AMZN260.21-5.82 (-2.19%) ▼|AVGO291.53-33.95 (-10.43%) ▼|AXP324.97-7.62 (-2.29%) ▼|BA172.50-4.50 (-2.54%) ▼|BAC49.76-1.87 (-3.62%) ▼|BKNG168.72-2.25 (-1.32%) ▼|BLK1,170.67-53.70 (-4.39%) ▼|BMY63.13-1.06 (-1.65%) ▼|BNY147.85-4.87 (-3.19%) ▼|BRK-B573.80-5.29 (-0.91%) ▼|C118.76-5.98 (-4.79%) ▼|CAT558.42-32.88 (-5.56%) ▼|CL98.81+0.05 (+0.05%) ▲|CMCSA24.81-0.05 (-0.18%) ▼|COF203.62-2.69 (-1.30%) ▼|COP137.51+0.57 (+0.42%) ▲|COST1,064.37+17.90 (+1.71%) ▲|CRM220.88-6.23 (-2.74%) ▼|CSCO96.04-7.57 (-7.31%) ▼|CVS80.35+0.39 (+0.48%) ▲|CVX215.74-1.22 (-0.56%) ▼|DE663.35-13.15 (-1.94%) ▼|DHR227.58-7.35 (-3.13%) ▼|DIS117.48-1.47 (-1.24%) ▼|DUK130.13+0.54 (+0.42%) ▲|EMR163.56-6.89 (-4.04%) ▼|FDX318.11-11.29 (-3.43%) ▼|GD358.91-5.96 (-1.63%) ▼|GE315.90-13.56 (-4.11%) ▼|GEV777.05-55.79 (-6.70%) ▼|GILD168.00-6.48 (-3.71%) ▼|GM89.14-3.29 (-3.56%) ▼|GOOG283.61-3.70 (-1.29%) ▼|GOOGL284.49-4.45 (-1.54%) ▼|GS871.57-56.43 (-6.08%) ▼|HD350.85-4.59 (-1.29%) ▼|HON216.94-11.53 (-5.05%) ▼|IBM247.77-6.55 (-2.58%) ▼|INTC53.58-4.69 (-8.05%) ▼|INTU351.82-4.82 (-1.35%) ▼|ISRG464.30-17.80 (-3.69%) ▼|JNJ272.50-3.82 (-1.38%) ▼|JPM337.31-14.80 (-4.20%) ▼|KO95.68-0.12 (-0.13%) ▼|LIN518.86-5.88 (-1.12%) ▼|LLY1,375.38-42.62 (-3.01%) ▼|LMT578.77-16.27 (-2.73%) ▼|LOW228.41-0.97 (-0.42%) ▼|LRCX190.22-31.22 (-14.10%) ▼|MA656.44-16.24 (-2.41%) ▼|MCD277.35-2.88 (-1.03%) ▼|MDLZ66.91-0.47 (-0.70%) ▼|MDT104.03-0.93 (-0.89%) ▼|META606.01-23.99 (-3.81%) ▼|MMM188.78-5.18 (-2.67%) ▼|MO77.34-0.67 (-0.86%) ▼|MRK147.31-3.05 (-2.03%) ▼|MS183.25-10.73 (-5.53%) ▼|MSFT535.26-20.54 (-3.70%) ▼|MU676.64-118.59 (-14.91%) ▼|NEE88.08-0.37 (-0.42%) ▼|NFLX64.88-1.52 (-2.28%) ▼|NKE39.45-1.05 (-2.58%) ▼|NOW102.06-6.75 (-6.20%) ▼|NVDA182.90-17.23 (-8.61%) ▼|ORCL115.23-8.50 (-6.87%) ▼|PEP143.42+1.00 (+0.70%) ▲|PFE30.09-0.70 (-2.27%) ▼|PG166.58-0.74 (-0.44%) ▼|PLTR155.02-16.68 (-9.71%) ▼|PM202.55-8.73 (-4.13%) ▼|QCOM158.93-14.26 (-8.23%) ▼|RTX192.54-5.89 (-2.97%) ▼|SBUX106.99-2.71 (-2.47%) ▼|SCHW92.64-0.73 (-0.78%) ▼|SO92.64-0.49 (-0.52%) ▼|SPG226.35-2.15 (-0.94%) ▼|T21.69-0.15 (-0.66%) ▼|TMO681.30-24.87 (-3.52%) ▼|TMUS159.77+0.60 (+0.38%) ▲|TSLA342.63-42.56 (-11.05%) ▼|TXN285.01-26.49 (-8.50%) ▼|UBER68.37-1.50 (-2.15%) ▼|UNH396.74-12.64 (-3.09%) ▼|UNP296.03-12.50 (-4.05%) ▼|UPS110.69-3.62 (-3.17%) ▼|USB59.48-1.55 (-2.54%) ▼|V424.45-12.12 (-2.78%) ▼|VZ46.12-0.06 (-0.12%) ▼|WFC84.48-2.95 (-3.37%) ▼|WMT128.11-1.06 (-0.82%) ▼|XOM167.58-1.70 (-1.00%) ▼|
21.1 C
New York
Thursday, November 5, 2026

Tag: health

newsFORsourcecompanycontentinformationreleases1market

2025 Half-Year results

The 2025 interim financial report, including the interim management report and the condensed consolidated interim financial statements at 30 June 2025, is available on the company’s website www.clariane.com. The condensed interim consolidated financial statements were approved by the Board of Directors at its meeting on 29 July 2025 and were subject to a limited review by the Statutory Auditors. The condensed interim consolidated financial statements have been prepared in accordance with IAS 34. For comparison purposes, the following financial information is presented excluding the application of IFRS 16

Rapid Expansion and Innovation Drive $36 Billion Global Point-of-Care Diagnostics Market, Says New Kalorama Report

ARLINGTON, Va., July 29, 2025 /PRNewswire/ -- A new report from Kalorama Information reveals that the global point-of-care (POC) diagnostics market surged past $36 billion...

Belly Fat Burner: Why Men and Women are Using Strong Over the Counter Diet Supplements like PhenQ to Lose Stubborn Abdominal Fat

New York City, NY, July 29, 2025 (GLOBE NEWSWIRE) --

In 2025, PhenQ is setting a new standard for belly fat burners with its research-driven, natural solution, providing powerful, long-lasting support for a slimmer, healthier stomach without injections or unwanted side effects, and supporting a healthier, more sustainable lifestyle.

Hansa Biopharma announces key executive appointments to support continued growth

LUND, Sweden, July 29, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced three leadership appointments. Brian Gorman joins Hansa as...

RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES IN THE FIRST HALF OF 2025 REVENUE +11.7%, EBITDA(1) +9.6%, ADJUSTED NET INCOME(2) +8.9%

Milan, 29th July 2025 – The Board of Directors of Recordati S.p.A. approved the interim financial statements as of June 30, 2025, pursuant to Art. 154-ter of Italian Legislative Decree 58/1998 and subsequent amendments, prepared in accordance with said Decree and the CONSOB Issuers Regulation. The statements were prepared in accordance with International Accounting Standard (IAS) 34 requirements for interim reporting, based on the assessment, measurement and recognition criteria set by the IFRSs. The interim financial statements on June 30, 2025 – as well as the Independent Auditors’ report on such statements - will be available within the legal deadline at the company’s offices and on the company’s website (www.recordati.com) and can also be viewed on the authorized storage system 1Info(www.1Info.it).

Claro Enterprise Solutions Partners with Nestlé to Streamline Connectivity Across LATAM

MIRAMAR, Fla., July 29, 2025 /PRNewswire/ -- Claro Enterprise Solutions is proud to announce its strategic partnership with Nestlé to deliver advanced connectivity services...

Back to School Summer Sleep Slide? Dr. Bedtime’s Book Gets Children Back On Track

SAN JOSE, Calif., July 29, 2025 /PRNewswire/ -- The Sleep to Live Well Foundation (STLW) announces the launch of its enchanting new children's book,...

TX RX Systems Launches Advanced DAS Monitoring System, Providing In-Building Signal Assurance for Public Safety

Game changing DAS Monitoring System launched by TX RX Systems Inc. This is the first of its kind to monitor multiple buildings at the same time.

Fruit and Vegetables Market Size Projected to Surpass USD 388.37 Billion by 2034, Backed by Organic and Fresh Produce Demand

According to Towards FnB, the global fruit and vegetables market size is evaluated at USD 244 billion in 2025 and is forecasted to hit around USD 388.37 billion by 2034, growing at a CAGR of 5.3% during the forecast period from 2025 to 2034. 
According to Towards FnB, the global fruit and vegetables market size is evaluated at USD 244 billion in 2025 and is forecasted to hit around USD 388.37 billion by 2034, growing at a CAGR of 5.3% during the forecast period from 2025 to 2034.

Cell Therapy Market to Reach USD 29.5 Billion by 2032, Growing at 21.5% CAGR | SkyQuest Technology Consulting

The cell therapy market is anticipated to expand at a rapid pace owing to high incidence of chronic diseases, growing demand for novel treatments,...

Cell Therapy Market to Reach USD 29.5 Billion by 2032, Growing at 21.5% CAGR | SkyQuest Technology Consulting

The cell therapy market is anticipated to expand at a rapid pace owing to high incidence of chronic diseases, growing demand for novel treatments,...

Bio Usawa Biotechnology and Sartorius Stedim Biotech Forge Partnership to Pioneer Biopharmaceutical Manufacturing in Africa

KIGALI, Rwanda and SAN FRANCISCO and AUBAGNE, France, July 29, 2025 (GLOBE NEWSWIRE) -- Bio Usawa Biotechnology, Ltd. (Bio Usawa), a leading African biotechnology firm, and Sartorius Stedim Biotech, a global partner of biopharmaceutical manufacturing, have announced a partnership to accelerate Africa’s biopharmaceutical industry and address the continent’s urgent, dual health burdens in infectious and non-communicable diseases.

Future is Bright for Academic Partnership Program at Canada’s National Nuclear Laboratory as Universities Agree to Five-Year Extensions

Innovative academic program contributes to a strong and sustainable talent pipeline for Canada’s national nuclear laboratories and Canadian nuclear sector 
Innovative academic program contributes to a strong and sustainable talent pipeline for Canada’s national nuclear laboratories and Canadian nuclear sector

Former AdventHealth President & CEO Terry Shaw Joins RAAPID Advisory Board

LOUISVILLE, Ky., July 29, 2025 /PRNewswire/ -- RAAPID, a M12 (Microsoft Venture Fund) backed company and leading AI-powered risk adjustment solutions provider, today announced the...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsHealth

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers